Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 8, 2026European Stroke JournalOpen Access

Abstract Number: Esoc2026a765 L-Arginine for Migrainous Encephalopathy and Receptive Aphasia in a Cadasil Patient

View Full Paper
Ask AI
Bookmark
Share

Authors

MKMarlan KayRSRachael Schutz

Discussion

Loading...

Member takes

Overview

Case report demonstrates l-arginine shows significant improvement in aphasia and symptoms in CADASIL patient, indicating potential for treatment.

Key Points

  • This report aims to evaluate the effects of l-arginine treatment on migrainous encephalopathy and aphasia in a CADASIL patient.
  • Described treatment course of l-arginine in a case study format.
  • Provided clinical observations, including MRI findings and symptom resolution details.
  • Monitored treatment tolerance and clinical progress over a 10-day inpatient rehabilitation period.
  • L-arginine treatment led to notable improvement in aphasia and vision in the CADASIL patient after dosage increase.
  • Initial symptoms included receptive aphasia, confusion, and severe headache, which improved with treatment.
  • NOTCH-3 genetic testing confirmed the diagnosis of CADASIL.

Cite This Study

Kay et al. (2026) studied this question.

synapsesocial.com/papers/69fd7e00bfa21ec5bbf063bchttps://doi.org/10.1093/esj/aakag023.422
View Full Paper
Ask AI
Bookmark
Share